Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
EHC
Strong BuyFull HouseFLAGEncompass Health Corporation · Healthcare · United States · $11.9B · Avg Vol: $112M/d
Encompass Health has quality Q71 and momentum M66 with a buyback on file, but value at V49 is one point below the calibrated floor, so stage one fails. Insider selling is separately adverse.
COMPANY DESCRIPTION
Encompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the United States, also providing comprehensive home health and hospice services. The company specializes in integrated post-acute care for patients recovering from complex medical conditions, offering high-quality, specialized rehabilitation programs. Its extensive network and commitment to clinical outcomes solidify its leadership position in the fragmented post-acute care market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3B | 4.8B | 5.4B | 5.9B | 10.9% | 6.2B | 6.5B | 7.0B | 8.5% |
| EPS | 2.72 | 3.51 | 4.53 | 5.62 | 27.4% | 5.99 | 6.30 | 6.89 | 10.7% |
| Shares | 99.8M | 100.3M | 100.8M | 100.0M | +0.2% | 98.7M | — | — | — |
| Debt | 3.0B | 2.9B | 2.7B | 2.7B | -3.2% | 2.8B | — | — | — |
| Equity | 1.3B | 1.6B | 2.1B | 2.4B | 23.0% | — | — | — | — |
| Op CF | 705.8M | 850.8M | 1.0B | 1.2B | 18.5% | 1.2B | — | — | — |
| Inv CF | -627.0M | -602.8M | -653.3M | -764.6M | — | — | — | — | — |
| Fin CF | -145.7M | -197.2M | -330.6M | -431.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of EHC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| EHC | Encompass Health Corporation(you) | $11.9B | 91 | Strong Buy |
| DVA | DaVita Inc. | $11.5B | 92 | Strong Buy |
| UHS | Universal Health Services, Inc. | $10.1B | 89 | Strong Buy |
| CHE | Chemed Corporation | $6.8B | 89 | Strong Buy |
| THC | Tenet Healthcare Corporation | $21.5B | 98 | Strong Buy |
| CON | Concentra Group Holdings Parent, Inc. | $4.4B | 93 | Strong Buy |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
| PACS | PACS Group, Inc. | $6.8B | 74 | Buy |
| LFST | LifeStance Health Group, Inc. | $4.7B | 80 | Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.9B | 96 | Strong Buy |
Peer medians: ROE -30.2% · P/E 27.1x · Gross margin 58.3%